Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia
International Journal of Oncology · 2023
DOI: 10.3892/ijo.2023.5576 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Oncology, 2023. Verfasst von Yoon Soo Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Nelfinavir, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
- Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
- Institute for Cancer Genetics and Joint Centers for Systems Biology, Columbia University, New York, NY 10032, USA.
Förderung
- Intramural NIH HHS
Zitieren
APA
Chang, Y. S., Gills, J. J., Kawabata, S., Onozawa, M., Della Gatta, G., Ferrando, A. A., Aplan, P. D., & Dennis, P. A. (2023). Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia. International Journal of Oncology. https://doi.org/10.3892/ijo.2023.5576
Vancouver
Chang YS, Gills JJ, Kawabata S, Onozawa M, Della Gatta G, Ferrando AA, et al. Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia. International Journal of Oncology. 2023. doi:10.3892/ijo.2023.5576
BibTeX
@article{Chang2023,
author = {Chang, Yoon Soo and Gills, Joell J and Kawabata, Shigeru and Onozawa, Masahiro and Della Gatta, Giusy and Ferrando, Adolfo A and Aplan, Peter D and Dennis, Phillip A},
title = {Inhibition of the NOTCH and mTOR pathways by nelfinavir as a novel treatment for T cell acute lymphoblastic leukemia},
journal = {International Journal of Oncology},
year = {2023},
doi = {10.3892/ijo.2023.5576}
}
EUVIMED